Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 18660489)

1.

Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.

Lu Y, Dollé ME, Imholz S, van 't Slot R, Verschuren WM, Wijmenga C, Feskens EJ, Boer JM.

J Lipid Res. 2008 Dec;49(12):2582-9. doi: 10.1194/jlr.M800232-JLR200. Epub 2008 Jul 25.

2.

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.

Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM Jr, Ballantyne CM, Marian AJ.

BMC Med Genet. 2009 Oct 30;10:111. doi: 10.1186/1471-2350-10-111.

3.

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

Arnedo M, Taffé P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; Swiss HIV Cohort Study.

Pharmacogenet Genomics. 2007 Sep;17(9):755-64.

PMID:
17700364
4.

Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.

Boekholdt SM, Souverein OW, Tanck MW, Hovingh GK, Kuivenhoven JA, Peters RI, Jansen H, Schiffers PM, van der Wall EE, Doevendans PA, Reitsma PH, Zwinderman AH, Kastelein JJ, Jukema JW.

Clin Genet. 2006 Mar;69(3):263-70.

PMID:
16542392
5.

CETP genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study.

Spielmann N, Leon AS, Rao DC, Rice T, Skinner JS, Bouchard C, Rankinen T.

Physiol Genomics. 2007 Sep 19;31(1):25-31. Epub 2007 May 22.

6.

Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia.

van Aalst-Cohen ES, Jansen AC, Boekholdt SM, Tanck MW, Fontecha MR, Cheng S, Li J, Defesche JC, Kuivenhoven JA, Kastelein JJ.

Eur J Hum Genet. 2005 Oct;13(10):1137-42.

7.

The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.

Dullaart RP, Borggreve SE, Hillege HL, Dallinga-Thie GM.

Scand J Clin Lab Invest. 2008;68(2):99-105. Epub 2007 Jul 10.

PMID:
17852818
8.

Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish obese subjects study.

Sarzynski MA, Jacobson P, Rankinen T, Carlsson B, Sjöström L, Carlsson LM, Bouchard C.

J Clin Endocrinol Metab. 2011 Jun;96(6):E953-7. doi: 10.1210/jc.2010-2227. Epub 2011 Mar 23.

PMID:
21430028
9.

Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.

Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.

Cell Biochem Funct. 2009 Oct;27(7):452-7. doi: 10.1002/cbf.1593.

PMID:
19784962
10.

Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein.

Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S, Maillot M, Gastaldi M, Darmon M, Portugal H, Lairon D, Planells R.

Br J Nutr. 2009 Mar;101(5):680-7. doi: 10.1017/S0007114508030754. Epub 2008 Jul 29.

PMID:
18662427
11.

Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus.

Porchay-Baldérelli I, Péan F, Emery N, Maimaitiming S, Bellili N, Travert F, Mohammedi K, Roussel R, Marre M, Fumeron F; DIABHYCAR Study Group.

Metabolism. 2009 Jan;58(1):74-9. doi: 10.1016/j.metabol.2008.08.009.

PMID:
19059534
12.

A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians.

Poduri A, Khullar M, Bahl A, Sharma YP, Talwar KK.

DNA Cell Biol. 2009 Sep;28(9):451-60. doi: 10.1089/dna.2009.0887.

PMID:
19558216
13.

Genetic determinants of plasma HDL-cholesterol levels in prepubertal children.

López-Simón L, de Oya M, Lasunción MA, Riestra P, Benavente M, de Oya I, Cano B, Schoppen S, Garcés C.

Clin Chim Acta. 2009 May;403(1-2):203-6. doi: 10.1016/j.cca.2009.03.002. Epub 2009 Mar 12.

PMID:
19285487
14.

Identification of genetic markers associated with high-density lipoprotein-cholesterol by genome-wide screening in a Japanese population: the Suita study.

Hiura Y, Shen CS, Kokubo Y, Okamura T, Morisaki T, Tomoike H, Yoshida T, Sakamoto H, Goto Y, Nonogi H, Iwai N.

Circ J. 2009 Jun;73(6):1119-26. Epub 2009 Apr 10.

16.

Analysis of multiple SNPs in genetic association studies: comparison of three multi-locus methods to prioritize and select SNPs.

Heidema AG, Feskens EJ, Doevendans PA, Ruven HJ, van Houwelingen HC, Mariman EC, Boer JM.

Genet Epidemiol. 2007 Dec;31(8):910-21.

PMID:
17615573
17.

Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol.

Knoblauch H, Bauerfeind A, Toliat MR, Becker C, Luganskaja T, Günther UP, Rohde K, Schuster H, Junghans C, Luft FC, Nürnberg P, Reich JG.

Hum Mol Genet. 2004 May 15;13(10):993-1004. Epub 2004 Mar 25.

18.
19.

Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol.

Spirin V, Schmidt S, Pertsemlidis A, Cooper RS, Cohen JC, Sunyaev SR.

Am J Hum Genet. 2007 Dec;81(6):1298-303.

20.

Prediction of genetic risk for dyslipidemia.

Yamada Y, Matsuo H, Warita S, Watanabe S, Kato K, Oguri M, Yokoi K, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y.

Genomics. 2007 Nov;90(5):551-8. Epub 2007 Oct 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk